Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Desroches, D. Rigal, C. Andreoni (1991)
Regulation and Functional Involvement of Distinct Determinants of Leucocyte Function‐Associated Antigen 1 (LFA‐1) in T‐Cell Activation In VitroScandinavian Journal of Immunology, 33
R. Rothlein, M. Czajkowski, M. O’Neill, S. Marlin, E. Mainolfi, V. Merluzzi (1988)
Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies.Journal of immunology, 141 5
A. Boyd, S. Wawryk, G. Burns, J. Fecondo (1988)
Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms.Proceedings of the National Academy of Sciences of the United States of America, 85 9
Paul Bohjanen, B. Petryniak, Carl June, Craig Thompson, T. Lindsten (1991)
An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNAMolecular and Cellular Biology, 11
A. Jevnikar, A. Jevnikar, R. Wuthrich, R. Wuthrich, F. Takei, F. Takei, Hong-Wu Xu, Hong-Wu Xu, Daniel Brennan, Daniel Brennan, L. Glimcher, L. Glimcher, V. Rubin‐Kelley, V. Rubin‐Kelley (1990)
Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells.Kidney international, 38 3
R. Stauder, R. Greil, T. Schulz, J. Thaler, C. Gattringer, T. Radaskiewicz, M. Dierich, H. Huber (1989)
Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.Clinical and experimental immunology, 77 2
Christopher Gregory, R. Murray, Carole Edwards, A. Rickinson (1988)
Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillanceThe Journal of Experimental Medicine, 167
J. Hildreth, F. Gotch, P. Hildreth, A. McMichael (1983)
A human lymphocyte‐associated antigen involved in cell‐mediated lympholysisEuropean Journal of Immunology, 13
M. Kuppner, Erwin Meir, M. Hamou, N. Tribolet (1990)
Cytokine regulation of intercellular adhesion molecule‐1 (ICAM‐1) expression on human glioblastoma cellsClinical & Experimental Immunology, 81
F. Sánchez‐Madrid, A. Krensky, C. Ware, E. Robbins, J. Strominger, S. Burakoff, T. Springer (1982)
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.Proceedings of the National Academy of Sciences of the United States of America, 79 23
S. Campbell, K. Tanabe, J. Alexander, M. Edinger, R. Tubbs, E. Klein (1994)
Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.The Journal of urology, 151 5
P. Busson, Qin Zhang, J. Guillon, C. Gregory, L. Young, B. Clausse, M. Lipinski, A. Rickinson, T. Tursz (1992)
Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in epstein‐barr‐virus‐positive nasopharyngeal carcinoma cellsInternational Journal of Cancer, 50
T. Wilson, R. Treisman (1988)
Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequencesNature, 336
M. Makgoba, M. Sanders, G. Luce, Michael Dustint, T. Springer, E. Clark, P. Mannoni, S. Shaw (1988)
ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cellsNature, 331
Y. Tomita, T. Nishiyama, Hisami Watanabe, M. Fujiwara, Shotaro Sato (1990)
Expression of intercellular adhesion molecule‐1 (ICAM‐1) on renal‐cell cancer: Possible significance in host immune responsesInternational Journal of Cancer, 46
F. Pandolfi, L. Trentin, L. Boyle, I. Stamenkovic, H. Byers, R. Colvin, J. Kurnick (2010)
Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor‐infiltrating lymphocytesCancer, 69
K. Kuijpers, T. Kuijpers, W. Zeijlemaker, C. Lucas, R. Lier, F. Miedema (1990)
Analysis of the role of leukocyte function-associated antigen-1 in activation of human influenza virus-specific T cell clones.Journal of immunology, 144 9
Mary Gerritsen, Keith Kelley, Gwenda Ligon, Carol Perry, Chien-Ping Shen, Andrew Szczepanski, William Carley (1993)
Regulation of the expression of intercellular adhesion molecule 1 in cultured human endothelial cells derived from rheumatoid synovium.Arthritis and rheumatism, 36 5
C. Fady, A. Gardner, J. Gera, A. Lichtenstein (1992)
Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.Cancer research, 52 4
D. Staunton, S. Marlin, C. Stratowa, Michael Dustin, T. Springer (1988)
Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene familiesCell, 52
G. Budd, B. Osgood, B. Barna, J. Boyett, J. Finke, S. Medendorp, S. Murthy, C. Novak, J. Sergi, R. Tubbs, R. Bukowski (1989)
Phase I Clinical Trial of Interleukin 2 and α-Interferon: Toxicity and Immunologic EffectsCancer Research, 49
G. Shaw, R. Kamen (1986)
A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradationCell, 46
A. Jackson, A. Alexandrov, S. Prescott, K. James, G. Chisholm (1992)
Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.Immunology, 76 2
T. Springer (1990)
Adhesion receptors of the immune systemNature, 346
C. Myers, S. Desai, J. Schembri-King, G. Letts, R. Wallace (1992)
Discriminatory effects of protein kinase inhibitors and calcium ionophore on endothelial ICAM-1 induction.The American journal of physiology, 262 2 Pt 1
W. Vogetseder, H. Feichtinger, T. Schulz, W. Schwaeble, P. Tabaczewski, M. Mitterer, Günther Böuck, C. Marth, O. Dapunt, G. Mikuz, M. Dierich (1989)
Expression of 7F7‐antigen, a human adhesion molecule identical to intercellular adhesion molecule‐1 (ICAM‐1) in human carcinomas and their stromal fibroblastsInternational Journal of Cancer, 43
Judith Johnson, B. Stade, B. Holzmann, Wilhelm Schwable, G. Riethmüller (1989)
De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.Proceedings of the National Academy of Sciences of the United States of America, 86 2
A. Grant, R. Merchant, R. Hall (1989)
Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.Immunology, 66 1
R. Wuthrich (1992)
Tumor Necrosis Factor-α- and lnterleukin-1-Stimulated Intercellular Adhesion Molecule-1 Expression by Murine Renal Tubular Epithelial Cells Is Transcriptionally Regulated and Involves Protein Kinase CKidney & Blood Pressure Research, 15
Carl Bigler, David Norris, William Weston, W. Arend (1992)
Interleukin-1 receptor antagonist production by human keratinocytes.The Journal of investigative dermatology, 98 1
H. Naganuma, R. Kiessling, M. Patarroyo, M. Hansson, R. Handgretinger, A. Grönberg (1991)
Increased susceptibility of ifn‐γ‐treated neuroblastoma cells to lysis by lymphokine‐activated killer cells: Participation of ICAM‐1 induction on target cellsInternational Journal of Cancer, 47
L. Lanier, M. Loken (1984)
Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression.Journal of immunology, 132 1
D. Cleveland, T. Yen (1989)
Multiple determinants of eukaryotic mRNA stability.The New biologist, 1 2
G. Siu, S. Hedrick, A. Brian (1989)
Isolation of the murine intercellular adhesion molecule 1 (ICAM-1) gene. ICAM-1 enhances antigen-specific T cell activation.Journal of immunology, 143 11
T. Ebert, N. Bander, C. Finstad, R. Ramsawak, Lloyd Old (1990)
Establishment and characterization of human renal cancer and normal kidney cell lines.Cancer research, 50 17
RL Kradin, DS Lazarus, SM Dubinett, J Gifford, B Grove, JT Kurnick, FI Pretter, CE Pinto, E Davison, RJ Collahan, HW Strauss (1989)
Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancerLancet, i
Jürgen Becker, R. Dummer, A. Hartmann, G. Burg, R. Schmidt (1991)
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.Journal of immunology, 147 12
F. Vánky, P. Wang, M. Patarroyo, Eva Klein (2005)
Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitroCancer Immunology, Immunotherapy, 31
Takayuki Hashimura, Raymond Tubbs, R. Connelly, Michael Caulfield, C. Trindade, James McMahon, Tommaso Galetti, Mark Edinger, Avery Sandberg, P. Cin, S. Sait, J. Pontes (1989)
Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma.Cancer research, 49 24 Pt 1
M. Makgoba, M. Sanders, G. Luce, E. Gugel, Michael Dustin, T. Springer, S. Shaw (1988)
Functional evidence that intercellular adhesion molecule‐1 (icam‐1) is a ligand for lfa‐1d‐ependent adhesion in t cell‐mediated cytotoxicityEuropean Journal of Immunology, 18
RP Wuthrich (1992)
Tumor necrosis factor-a-and interleukin1-stimulated intercellular adhesion molecule-1 expression by murine renal tubular epithelial cells is transcriptionally regulated and involves protein kinase CRenal Physiol Biochem, 15
R. Kradin, A. Bhan (1993)
Tumor infiltrating lymphocytes.Laboratory investigation; a journal of technical methods and pathology, 69 6
S. Wertheimer, C. Myers, R. Wallace, T. Parks (1992)
Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate.The Journal of biological chemistry, 267 17
P. Natali, M. Nicotra, R. Cavaliere, A. Bigotti, G. Romano, M. Temponi, S. Ferrone (1990)
Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.Cancer research, 50 4
M. Billaud, A. Calender, J. Seigneurin, G. Lenoir (1987)
LFA-1, LFA-3, AND ICAM-1 EXPRESSION IN BURKITT'S LYMPHOMAThe Lancet, 330
S. Rosenberg, M. Lotze, L. Muul, A. Chang, F. Avis, S. Leitman, W. Linehan, C. Robertson, R. Lee, J. Rubin, C. Seipp, Colleen Simpson, D. White (1987)
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.The New England journal of medicine, 316 15
Michael Dustin, R. Rothlein, A. Bhan, C. Dinarello, T. Springer (1986)
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).Journal of immunology, 137 1
(1996)
The expression of CD44 and CD54 by renal cell carcinoma and their role in cytolysis mediated by autologous tumor infiltrating lymphocytes (TIL) and in IL2 dependent TIL proliferation
A. Belldegrun, L. Muul, S. Rosenberg (1988)
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.Cancer research, 48 1
JC Becker, R Dummer, AA Hartmann, G Burg, RE Schmidt (1991)
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-αJ Immunol, 147
Intercellular adhesion molecule-1 (ICAM-1) mediates two important functional. aspects of tumor biology, namely enhancement of tumor metastasis and mediation of host defense mechanisms such as lymphocyte-mediated tumor cytotoxicity. Since ICAM-1 is expressed by most renal cell carcinomas (RCC), the regulation of ICAM-1 expression is important in understanding the biological behavior of RCC. We report an investigation on ICAM-1 expression and molecular regulation by cytokines and protein kinase C activator on RCC cell lines. Of the various cytokines, tumor necrosis factor αa (TNFα), interferon-γ (IFNγ), and phorbol myristate acetate (PMA) strongly upregulated ICAM-1 protein expression on RCC. The kinetics of ICAM-1 message induction was studied by Northern analysis of total RNA extracted from RCC and normal kidney proximal tubular (NKPT) cells. Time course studies showed that ICAM-1 mRNA was upregulated by INFγ, TNFα, and PMA, plateaued after 2 h, and remained increased for up to 24 h. Although ICAM-1 mRNA in NKPT cells was upregulated by these cytokines, their messages returned to basal levels after 24 h. ICAM-1 mRNA stability assays showed that both unstimulated and stimulated RCC cells had very stable ICAM-1 mRNA up to 24 h. In order to investigate whether increased gene transcription contributes to ICAM-1 upregulation, RCC cells were treated with TNFα, IFNγ, or PMA with or without simultaneous addition of actinomycin D. ICAM-1 message induction-blocking studies suggested that primary upregulation of ICAM-1 mRNA may be caused by transcriptional upregulation. These results suggest that long-lasting ICAM-1 message upregulation in response to cytokines or PMA may be due to transcriptional upregulation in the early phase and stabilization of ICAM-1 message in the later phase (after 4 h). These observations suggest that RCC may lack the normal downregulatory mechanisms which control ICAM-1 expression and may explain the high frequency of ICAM-1 expression observed on primary human RCC.
Urological Research – Springer Journals
Published: Dec 21, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.